Fennec Pharmaceuticals (FENC) CSO Christiana Cioffi Receives Award

What Happened Christiana Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals (FENC), received 156 shares on 2026-08-31 as the release of previously restricted stock. The shares were acquired at $0.00 per share (total reported value $0) — this was a release/award vesting event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-31
• Transaction type/code: Award/release of restricted shares (code A)
• Shares involved: 156 shares acquired at $0.00 each (total $0)
• Shares owned after transaction: Not specified in the filing
• Footnote: F1 — Represents shares released from restriction from shares awarded 3/28/2025
• Filing timeliness: Form 4 filed with the report date 2026-08-31; no late filing indicated

Context This entry reflects the vesting/release of previously awarded restricted stock, a common form of executive compensation. Such releases do not involve an out-of-pocket purchase and should be viewed as compensation/vesting activity rather than a direct bullish or bearish trading signal.